Terms: = Liver cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306
39 results:
1. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
Li Y; Tao T; Liu Y
BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study.
Shao G; Fan Z; Qiu W; Lv G
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16489-16499. PubMed ID: 37712961
[TBL] [Abstract] [Full Text] [Related]
3. Cell-in-Cell-Mediated Entosis Reveals a Progressive Mechanism in Pancreatic cancer.
Song J; Xu R; Zhang H; Xue X; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Gastroenterology; 2023 Dec; 165(6):1505-1521.e20. PubMed ID: 37657757
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a diagnostic model for AFP-negative hepatocellular carcinoma.
Yu Z; Chen D; Zheng Y; Wang X; Huang S; Lin T; Lin Y; Zhang Y; Huang Y; Ou Q; Huang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11295-11308. PubMed ID: 37368120
[TBL] [Abstract] [Full Text] [Related]
5. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases.
Sun C; Liu X; Sun J; Dong L; Wei F; Bao C; Zhong J; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9543-9555. PubMed ID: 37221440
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer.
Xia J; Xie Z; Niu G; Lu Z; Wang Z; Xing Y; Ren J; Hu Z; Hong R; Cao Z; Han S; Chu Y; Liu R; Ke C
Immunology; 2023 Jan; 168(1):135-151. PubMed ID: 36082430
[TBL] [Abstract] [Full Text] [Related]
7. The Mitochondrial Citrate Carrier SLC25A1/cic and the Fundamental Role of Citrate in cancer, Inflammation and Beyond.
Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
[TBL] [Abstract] [Full Text] [Related]
8. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
[TBL] [Abstract] [Full Text] [Related]
9. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
de Vries E; Mazzetti M; Takkenberg B; Mostafavi N; Bikker H; Marzioni M; de Veer R; van der Meer A; Doukas M; Verheij J; Beuers U
Liver Int; 2020 Dec; 40(12):3042-3050. PubMed ID: 32893960
[TBL] [Abstract] [Full Text] [Related]
10. Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma.
Hayashi A; Yavas A; McIntyre CA; Ho YJ; Erakky A; Wong W; Varghese AM; Melchor JP; Overholtzer M; O'Reilly EM; Klimstra DS; Basturk O; Iacobuzio-Donahue CA
Mod Pathol; 2020 Sep; 33(9):1822-1831. PubMed ID: 32350415
[TBL] [Abstract] [Full Text] [Related]
11. Pancreaticoduodenectomy for a primary duodenal capicua transcriptional repressor (cic) -rearranged sarcoma with severe bleeding: a case report.
Aoki Y; Oshiro H; Yoshida A; Morishima K; Miki A; Sasanuma H; Sakuma Y; Lefor AK; Sata N
BMC Gastroenterol; 2020 Apr; 20(1):105. PubMed ID: 32293288
[TBL] [Abstract] [Full Text] [Related]
12. Regulation and function of capicua in mammals.
Lee Y
Exp Mol Med; 2020 Apr; 52(4):531-537. PubMed ID: 32238859
[TBL] [Abstract] [Full Text] [Related]
13. Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma.
Hashiba T; Yamashita T; Okada H; Nio K; Hayashi T; Asahina Y; Hayashi T; Terashima T; Iida N; Takatori H; Shimakami T; Kawaguchi K; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Takamura H; Ohta T; Honda M; Kaneko S
Cell Mol Gastroenterol Hepatol; 2020; 10(2):269-285. PubMed ID: 32169577
[TBL] [Abstract] [Full Text] [Related]
14. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
[TBL] [Abstract] [Full Text] [Related]
15. Chloride channel 3 (cic-3) predicts the tumor size in hepatocarcinoma.
Cheng W; Zheng S; Li L; Zhou Q; Zhu H; Hu J; Luo H
Acta Histochem; 2019 Apr; 121(3):284-288. PubMed ID: 30678806
[TBL] [Abstract] [Full Text] [Related]
16. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
Zubiete-Franco I; García-Rodríguez JL; Lopitz-Otsoa F; Serrano-Macia M; Simon J; Fernández-Tussy P; Barbier-Torres L; Fernández-Ramos D; Gutiérrez-de-Juan V; López de Davalillo S; Carlevaris O; Beguiristain Gómez A; Villa E; Calvisi D; Martín C; Berra E; Aspichueta P; Beraza N; Varela-Rey M; Ávila M; Rodríguez MS; Mato JM; Díaz-Moreno I; Díaz-Quintana A; Delgado TC; Martínez-Chantar ML
EBioMedicine; 2019 Feb; 40():406-421. PubMed ID: 30594553
[TBL] [Abstract] [Full Text] [Related]
17. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
[TBL] [Abstract] [Full Text] [Related]
18. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
[TBL] [Abstract] [Full Text] [Related]
19. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) cic-DUX4 gene fusion.
Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
[TBL] [Abstract] [Full Text] [Related]
20. Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
Lu AQ; Lv B; Qiu F; Wang XY; Cao XH
Oncol Rep; 2017 Apr; 37(4):2071-2078. PubMed ID: 28350139
[TBL] [Abstract] [Full Text] [Related]
[Next]
